Letter: ustekinumab for the treatment of post-surgical and refractory Crohn's disease. Tursi A, Mocci G, Picchio M, Elisei W, et al. Aliment Pharmacol Ther 2021;53:859-860.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tursi A, Mocci G, Picchio M, Elisei W, et al. Letter: ustekinumab for the treatment of post-surgical and refractory Crohn's disease. Aliment Pharmacol Ther 2021;53:859-860.
PMID: 33709395